Search
-
NewsSKI Study Sheds Light on How a Natural Defense Against Viruses Can Lead to Mutations in Cancer Cells
A protein in the body that protects against viruses can also cause cancer-related mutations.
… Wednesday, July 20, 2022 The body deploys many weapons to defend against internal and external threats. One tactic used by cells involves a group of proteins called APOBEC3 enzymes. These enzymes can disable viruses by disrupting the invaders’ genetic material. They also protect against certain genetic
-
News
Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
… Friday, May 31, 2024 As Susan Everson lay in bed recovering from colorectal cancer surgery at Memorial Sloan Kettering Cancer Center (MSK), a nurse walked into her room with bag of cosmetics and a big dose of compassion. Using her skills as a professionally trained makeup artist, she’d come to help Susan
-
News
A study led by postdoctoral researcher Yanan Ma from the lab of cell biologist Philipp Niethammer shows why diversity also matters in model animal research.
… Tuesday, January 10, 2023 In science, how you ask a question is often as important as what you ask. Philipp Niethammer Philipp Niethammer, PhD The lab of cell biologist Philipp Niethammer, PhD , of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center (MSK), studies fast-acting mechanisms
-
News
Investigators are looking at how and why the breast cancer drug trastuzumab sometimes causes long-lasting and potentially serious cardiac side effects.
… Thursday, October 19, 2017 Summary The breast cancer drug trastuzumab, which targets a protein called HER2, can cause long-lasting and potentially serious cardiac side effects. Researchers are using stem cells to study why this happens and to look for ways to prevent it. For people with breast cancer
-
News
Learn about how to cope with grief during the holidays from MSK Experts.
… Tuesday, December 13, 2016 Summary MSK experts provide advice on how to cope with grief during the holiday season. It’s important to reevaluate rituals, seek support, and remain aware of your own mental health. Highlights Seek support: Surround yourself with others who’ve experienced what you have. Accept
-
News
Expand your knowledge of melanoma with these surprising facts.
… Tuesday, May 11, 2021 Summary Does melanoma always develop from a mole? Can melanoma be pink? Read on to expand your knowledge of the disease. Compared to other cancers, melanoma may seem fairly straightforward. But there’s more to this disease than meets the eye. Dermatologist Ashfaq Marghoob of the
-
News
Adding idelalisib (Zydelig®) to a standard chemotherapy regimen of bendamustine and rituximab (BR) significantly increases progression-free survival (PFS) and overall survival (OS) in patients with relapsed or treatment-resistant chronic lymphocytic leukemia (CLL) as compared with BR alone, according to new findings presented by a Memorial Sloan Kettering (MSK) investigator on behalf of his international co-investigators. Results from the phase III study were presented as part of the press program at this year’s American Society of Hematology annual meeting.
… Sunday, December 6, 2015 Adding idelalisib (Zydelig®) to a standard chemotherapy regimen of bendamustine and rituximab (BR) significantly increases progression-free survival (PFS) and overall survival (OS) in patients with relapsed or treatment-resistant chronic lymphocytic leukemia (CLL) as compared
-
News
MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults.
… Wednesday, January 20, 2016 Summary MSK medical oncologist David Straus is looking for less-intensive treatments for Hodgkin lymphoma, a type of blood cancer most commonly found in young adults. While cure rates for the disease are high, the standard treatment often results in serious side effects that
-
News
The online resource will serve as a benchmark for researchers studying metabolism and cancer.
… Wednesday, January 24, 2018 Summary Researchers are increasingly drawn to the study of metabolism , the collective suite of chemical reactions occurring in cells, for answers to questions about cancer. A new searchable database aids that quest. Scientists from Memorial Sloan Kettering and the Dana-Farber
-
Newsroom
Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments.
… Monday, February 10, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments: MSK Board of Trustees Member David M. Rubenstein Received the Presidential Medal of Freedom David M. Rubenstein Board of Trustees member David M. Rubenstein received the Presidential